Meta AnalysisID 4701

尿素基乳膏与吡哆醇(维生素B6)对肝细胞癌患者索拉非尼诱导的手足综合征/皮肤反应的效果:一项系统评价和Meta分析

CRD42022340121

To compare the effectiveness of urea-based cream and pyridoxine(vitamin b6) in treating sorafenib-induced hand-foot syndrome in hepatocellular carcinoma patients.

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
4701
Evidence Id
13259
Core Evidence Id
13259
Source Meta Analysis Id
4669
Herb2 Meta Analysis Id
HBMA004669
Crd Id
CRD42022340121
Title
Effectiveness of Urea-Based Cream and Pyridoxine(vitamin B6) on Sorafenib-induced Hand-foot Syndrome/skin reaction in hepatocellular carcinoma patients: A Systematic Review and Meta-analysis
Review Question
To compare the effectiveness of urea-based cream and pyridoxine(vitamin b6) in treating sorafenib-induced hand-foot syndrome in hepatocellular carcinoma patients.
Study Type Included
Only Randomized Controlled Trials (RCTs) will be included in this study.
Condition Being Studied
Sorafenib is a multitargeted tyrosine kinase inhibitor, which has been mainly used in the treatment of advanced hepatocellular carcinoma. During the treatment, sorafenib can cause a variety of toxic reactions, such as hand-foot syndrome / skin reaction, hypertension, arterial thromboembolism, diarrhea and so on. Hand-foot Syndrome (HFS)/skin reaction(HFSR) is considered the most clinically significant dermatologic adverse event. For patients, these debilitating symptoms hinder their ability to perform activities of daily living and cause a significant financial burden, thus leading to a reduced quality of life. In treatment, according to NCCN guidelines, will reduce the dose, change the regimen, and discontinue the treatment, and it will significantly affect the anti-tumor efficacy. Clinically, patients are often advised to apply emollient ointments, urea-based cream, prophylactic vitamin E, vitamin B6, or use COX-2 inhibitors , etc. However, the efficacy is uncertain. To date, the treatment effectiveness between urea-based cream and pyridoxine(vitamin B6) have not been systematic evaluated.
Participant
Hepatocellular carcinoma patients using sorafenib.
Animal
Human Disease Modelled
Intervention
(1) Urea-based cream applied on hands or feet; (2) pyridoxine(vitamin b6) as treatment;
Comparator Control
The intervention which not include Urea-based cream applied on hands or feet or pyridoxine(vitamin b6) as treatment, will be any other kind of therapy including hydrocolloid dressing, apply moisturizing creams(do not include urea based cream and vitB6); wear thick cotton gloves and/or socks at night, nutritious medicine, etc.
Main Outcome
(1)Incidence of HFS of any grade (according to the criteria of National Cancer Institute Common Terminology Criteria for Adverse Events, NCI-CTCAE version 4.03); (2)Recovery of HFS; (3)Any other outcomes reported in the eligible studies will be extracted, synthesized and reported.
Outcome Measure
Additional Outcome
Time to development of HFS; Activity of Daily Life(ADL); Pain Score; Quality of life; Incidence of Treatment Interruption or Discontinuation;
Study Method
Meta-analysis, Systematic review
Keyword
Carcinoma, Hepatocellular; Hand-Foot Syndrome; Humans; Liver Neoplasms; Pyridoxine; Sorafenib
Contact
WangRui [email protected]
Organisational Affiliation
Chong Qing Medical University
Funding Source
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
China
Review Stage
Review Ongoing
First Submission Date
2022-08-30
Registration Date
2022-09-10
Anticipated Start Date
2022-07-01
Anticipated Completion Date
2022-09-30
Title Cn
尿素基乳膏与吡哆醇(维生素B6)对肝细胞癌患者索拉非尼诱导的手足综合征/皮肤反应的效果:一项系统评价和Meta分析
Title En
Effectiveness of Urea-Based Cream and Pyridoxine(vitamin B6) on Sorafenib-induced Hand-foot Syndrome/skin reaction in hepatocellular carcinoma patients: A Systematic Review and Meta-analysis
Bilingual Status
complete